// App-Quantinova.ai

3029 : Dual targeting of ARK5 and CDK4 pathways with ON 123300 as a therapeutic strategy for colorectal carcinoma

Researchers

Presenter

  • Saikrishna A. Divakar

Principal Investigators

  • M.V. Ramana Reddy

  • Stephen C. Cosenza

  • Stacey J. Baker

  • Vinee Purohit

  • Venugopal Gunda

  • Pankaj K. Singh

  • E. Premkumar Reddy

Medical Centers

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • Icahn School of Medicine at Mount Sinai, Manhattan, NY.

  • University of Nebraska Medical Center, Omaha, NE

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • AMP-activated protein kinase

  • Cyclin D1

  • Cyclin-dependent kinase 4

Drug/Treatment

  • Palbociclib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved